Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05166785 · ClinicalTrials.gov registry record · NA

BRInging the Diabetes Prevention Program to GEriatric Populations

A NA study of PreDiabetes, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
238
Enrollment target
1
Study location

NCT05166785: Active NA study of PreDiabetes, sponsored by NYU Langone Health.

NCT05166785 is a NA study of PreDiabetes that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 238 participants, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05166785, a NA study of PreDiabetes, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
238 participants
Enrollment target
1
Study location

Study Summary

Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction of diabetes after an average follow-up of 3 years. The population of older adults is projected to more than double from 52.5 million in 2019 to \~100 million by 2060, and if projections hold, about half (48.3%) will have prediabetes. The proposed hybrid effectiveness implementation type 1 design will compare a DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) to an in person DPP tailored for older adults (DPP arm) using a randomized, controlled trial design (n=230). The preliminary data suggests DPP-TOAT is a feasible and acceptable way to deliver the DPP to older adults, and this will be the first study to compare the effectiveness and implementation of two strategies (telehealth versus in-person) to deliver a tailored DPP for the unique needs of the growing population of older adults.

Primary Outcome

In-person outcome assessment visits at the New York University Langone research clinic to measure weight at baseline, 6, and 12 months among all randomized participants

Conditions Studied

Interventions

  • OTHER DPP Tailored for Older Adults and delivered via Telehealth
  • OTHER In-Person Diabetes Prevention Program (DPP)

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2022-10-05
Est. Completion 2026-11
Phase NA
NYU Langone Health

1,164 total trials

What the registry record for NCT05166785 still lists

NCT05166785 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (66% lower).

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which DPP Tailored for Older Adults and delivered via Telehealth is the first listed.

NCT05166785 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05166785 about?

NCT05166785 is a clinical study titled "BRInging the Diabetes Prevention Program to GEriatric Populations". Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction ...

What is the current status of trial NCT05166785?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2022-10-05. Estimated completion is 2026-11.

What conditions does trial NCT05166785 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT05166785?

The interventions under investigation include: DPP Tailored for Older Adults and delivered via Telehealth (OTHER), In-Person Diabetes Prevention Program (DPP) (OTHER).

Who is sponsoring clinical trial NCT05166785?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05166785 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05166785's enrollment target sits among peer trials

238 34th of 149 higher than 116 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

  • NCT06452797 · 238 participants · NA

    Prognostic Estimates Among ICU Clinicians

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05166785, the US trial registry maintained by the National Library of Medicine. NCT05166785 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.